Jardiance 10 mg film-coated tablets
Jardiance 25 mg film-coated tablets
Jardiance 10 mg film-coated tablets
Each tablet contains 10 mg empagliflozin.
Excipients with known effect
Each tablet contains lactose monohydrate equivalent to 154.3 mg lactose anhydrous.
Jardiance 25 mg film-coated tablets
Each tablet contains 25 mg empagliflozin.
Excipients with known effect
Each tablet contains lactose monohydrate equivalent to 107.4 mg lactose anhydrous.
For the full list of excipients, see section 6.1.
Film-coated tablet (tablet).
Jardiance 10 mg film-coated tablets
Round, pale yellow, biconvex, bevel-edged film-coated tablet debossed with “S10” on one side and the Boehringer Ingelheim logo on the other (tablet diameter: 9.1 mm).
Jardiance 25 mg film-coated tablets
Oval, pale yellow, biconvex film-coated tablet debossed with “S25” on one side and the Boehringer Ingelheim logo on the other (tablet length: 11.1 mm, tablet width: 5.6 mm).
Type 2 diabetes mellitus
Jardiance is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise
- as monotherapy when metformin is considered inappropriate due to intolerance
- in addition to other medicinal products for the treatment of diabetes
For study results with respect to combinations, effects on glycaemic control and cardiovascular events, and the populations studied, see sections 4.4, 4.5 and 5.1.
Heart failure
Jardiance is indicated in adults for the treatment of symptomatic chronic heart failure.
UK Relactagel Vaginal Gel